nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Topotecan—ovarian cancer	0.167	0.387	CbGbCtD
Clofarabine—ABCG2—Paclitaxel—ovarian cancer	0.0826	0.191	CbGbCtD
Clofarabine—ABCG2—Carboplatin—ovarian cancer	0.0777	0.18	CbGbCtD
Clofarabine—ABCG2—Docetaxel—ovarian cancer	0.0597	0.138	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—ovarian cancer	0.0445	0.103	CbGbCtD
Clofarabine—POLA1—myometrium—ovarian cancer	0.00442	0.0369	CbGeAlD
Clofarabine—RRM2—myometrium—ovarian cancer	0.00422	0.0352	CbGeAlD
Clofarabine—RRM2—embryo—ovarian cancer	0.00406	0.0339	CbGeAlD
Clofarabine—RRM1—myometrium—ovarian cancer	0.00351	0.0293	CbGeAlD
Clofarabine—POLA1—uterine cervix—ovarian cancer	0.00344	0.0287	CbGeAlD
Clofarabine—POLA1—Vinblastine—Vinorelbine—ovarian cancer	0.00333	0.675	CbGdCrCtD
Clofarabine—RRM2—uterine cervix—ovarian cancer	0.00329	0.0274	CbGeAlD
Clofarabine—POLA1—decidua—ovarian cancer	0.00328	0.0273	CbGeAlD
Clofarabine—RRM2—decidua—ovarian cancer	0.00313	0.0261	CbGeAlD
Clofarabine—POLA1—endometrium—ovarian cancer	0.00311	0.0259	CbGeAlD
Clofarabine—Cladribine—NR5A1—ovarian cancer	0.00307	1	CrCbGaD
Clofarabine—RRM2—endometrium—ovarian cancer	0.00297	0.0248	CbGeAlD
Clofarabine—RRM2—gonad—ovarian cancer	0.00276	0.023	CbGeAlD
Clofarabine—RRM2—uterus—ovarian cancer	0.00274	0.0228	CbGeAlD
Clofarabine—RRM1—uterine cervix—ovarian cancer	0.00273	0.0228	CbGeAlD
Clofarabine—DCK—myometrium—ovarian cancer	0.00272	0.0227	CbGeAlD
Clofarabine—DCK—embryo—ovarian cancer	0.00262	0.0219	CbGeAlD
Clofarabine—RRM1—decidua—ovarian cancer	0.0026	0.0217	CbGeAlD
Clofarabine—RRM1—endometrium—ovarian cancer	0.00247	0.0206	CbGeAlD
Clofarabine—RRM2—female reproductive system—ovarian cancer	0.00246	0.0205	CbGeAlD
Clofarabine—POLA1—bone marrow—ovarian cancer	0.00243	0.0203	CbGeAlD
Clofarabine—POLA1—female gonad—ovarian cancer	0.00234	0.0196	CbGeAlD
Clofarabine—POLA1—vagina—ovarian cancer	0.00233	0.0194	CbGeAlD
Clofarabine—RRM2—bone marrow—ovarian cancer	0.00232	0.0194	CbGeAlD
Clofarabine—RRM1—gonad—ovarian cancer	0.00229	0.0191	CbGeAlD
Clofarabine—RRM1—uterus—ovarian cancer	0.00227	0.019	CbGeAlD
Clofarabine—RRM2—female gonad—ovarian cancer	0.00224	0.0187	CbGeAlD
Clofarabine—RRM2—vagina—ovarian cancer	0.00223	0.0186	CbGeAlD
Clofarabine—DCK—uterine cervix—ovarian cancer	0.00212	0.0177	CbGeAlD
Clofarabine—POLA1—testis—ovarian cancer	0.00208	0.0173	CbGeAlD
Clofarabine—RRM1—female reproductive system—ovarian cancer	0.00205	0.0171	CbGeAlD
Clofarabine—DCK—decidua—ovarian cancer	0.00202	0.0169	CbGeAlD
Clofarabine—RRM2—testis—ovarian cancer	0.00199	0.0166	CbGeAlD
Clofarabine—RRM1—bone marrow—ovarian cancer	0.00193	0.0161	CbGeAlD
Clofarabine—DCK—endometrium—ovarian cancer	0.00192	0.016	CbGeAlD
Clofarabine—RRM1—female gonad—ovarian cancer	0.00186	0.0155	CbGeAlD
Clofarabine—RRM1—vagina—ovarian cancer	0.00185	0.0154	CbGeAlD
Clofarabine—DCK—gonad—ovarian cancer	0.00178	0.0148	CbGeAlD
Clofarabine—DCK—uterus—ovarian cancer	0.00177	0.0147	CbGeAlD
Clofarabine—RRM1—testis—ovarian cancer	0.00165	0.0138	CbGeAlD
Clofarabine—DCK—female reproductive system—ovarian cancer	0.00159	0.0133	CbGeAlD
Clofarabine—ABCG2—myometrium—ovarian cancer	0.00152	0.0127	CbGeAlD
Clofarabine—POLA1—lymph node—ovarian cancer	0.00151	0.0126	CbGeAlD
Clofarabine—DCK—bone marrow—ovarian cancer	0.0015	0.0125	CbGeAlD
Clofarabine—DCK—female gonad—ovarian cancer	0.00145	0.0121	CbGeAlD
Clofarabine—RRM2—lymph node—ovarian cancer	0.00144	0.012	CbGeAlD
Clofarabine—DCK—vagina—ovarian cancer	0.00144	0.012	CbGeAlD
Clofarabine—DCK—testis—ovarian cancer	0.00128	0.0107	CbGeAlD
Clofarabine—RRM1—lymph node—ovarian cancer	0.0012	0.00998	CbGeAlD
Clofarabine—ABCG2—uterine cervix—ovarian cancer	0.00118	0.00987	CbGeAlD
Clofarabine—ABCG2—decidua—ovarian cancer	0.00113	0.0094	CbGeAlD
Clofarabine—ABCG2—endometrium—ovarian cancer	0.00107	0.00892	CbGeAlD
Clofarabine—ABCG2—uterus—ovarian cancer	0.000986	0.00822	CbGeAlD
Clofarabine—DCK—lymph node—ovarian cancer	0.000929	0.00775	CbGeAlD
Clofarabine—ABCG2—bone marrow—ovarian cancer	0.000837	0.00698	CbGeAlD
Clofarabine—DCK—Doxorubicin—Epirubicin—ovarian cancer	0.000831	0.169	CbGdCrCtD
Clofarabine—ABCG2—female gonad—ovarian cancer	0.000806	0.00673	CbGeAlD
Clofarabine—ABCG2—vagina—ovarian cancer	0.000801	0.00669	CbGeAlD
Clofarabine—DCK—Epirubicin—Doxorubicin—ovarian cancer	0.000768	0.156	CbGdCrCtD
Clofarabine—ABCG2—testis—ovarian cancer	0.000715	0.00597	CbGeAlD
Clofarabine—ABCG2—lymph node—ovarian cancer	0.000518	0.00432	CbGeAlD
Clofarabine—POLA1—Telomere Maintenance—TERT—ovarian cancer	0.000389	0.00233	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000387	0.00232	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000384	0.0023	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000383	0.0023	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—PPP2R1A—ovarian cancer	0.000375	0.00225	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000366	0.00219	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1B—ovarian cancer	0.000363	0.00218	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—ovarian cancer	0.000361	0.00216	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	0.00036	0.00216	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000352	0.00211	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PPP1CC—ovarian cancer	0.000351	0.0021	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CCNE1—ovarian cancer	0.000348	0.00209	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PPP1CC—ovarian cancer	0.000343	0.00205	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—TYMS—ovarian cancer	0.000342	0.00205	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—ovarian cancer	0.000338	0.00202	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000335	0.00201	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—TERT—ovarian cancer	0.000324	0.00194	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NME2—ovarian cancer	0.000318	0.0019	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCNE1—ovarian cancer	0.000316	0.00189	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000316	0.00189	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000316	0.00189	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RBL2—ovarian cancer	0.000315	0.00189	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000301	0.00181	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000301	0.0018	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000296	0.00178	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000295	0.00177	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000293	0.00176	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000293	0.00176	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TYMS—ovarian cancer	0.000288	0.00173	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000284	0.0017	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—ABCB1—ovarian cancer	0.000284	0.0017	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000282	0.00169	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—MYC—ovarian cancer	0.000278	0.00167	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000271	0.00162	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RAD51C—ovarian cancer	0.000268	0.00161	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDKN1B—ovarian cancer	0.000264	0.00158	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000262	0.00157	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NME2—ovarian cancer	0.000261	0.00157	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000254	0.00152	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN1B—ovarian cancer	0.000249	0.00149	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NME2—ovarian cancer	0.000244	0.00146	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—TERT—ovarian cancer	0.000243	0.00146	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000242	0.00145	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000241	0.00144	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000241	0.00144	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PPP1CC—ovarian cancer	0.000234	0.00141	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000234	0.0014	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000229	0.00137	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000226	0.00135	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000222	0.00133	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000222	0.00133	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000222	0.00133	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000221	0.00132	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000218	0.00131	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000216	0.00129	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RBL2—ovarian cancer	0.000215	0.00129	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.000212	0.00127	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MLH1—ovarian cancer	0.000212	0.00127	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—SKP2—ovarian cancer	0.000209	0.00126	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—ovarian cancer	0.000208	0.00125	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000206	0.00124	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYTB—ovarian cancer	0.000205	0.00123	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000204	0.00123	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—ovarian cancer	0.000202	0.00121	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.0002	0.0012	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—ovarian cancer	0.0002	0.0012	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000198	0.00119	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000195	0.00117	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000193	0.00116	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—ovarian cancer	0.00019	0.00114	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000188	0.00113	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDKN1B—ovarian cancer	0.000187	0.00112	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	0.000187	0.00112	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000185	0.00111	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CDKN1B—ovarian cancer	0.00018	0.00108	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.00018	0.00108	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPP1CC—ovarian cancer	0.000179	0.00107	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—BRIP1—ovarian cancer	0.000179	0.00107	CbGpPWpGaD
Clofarabine—Hypertension—Paclitaxel—ovarian cancer	0.000176	0.000644	CcSEcCtD
Clofarabine—Alopecia—Docetaxel—ovarian cancer	0.000176	0.000641	CcSEcCtD
Clofarabine—Pruritus—Vinorelbine—ovarian cancer	0.000175	0.00064	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000175	0.000637	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000175	0.000637	CcSEcCtD
Clofarabine—Mental disorder—Docetaxel—ovarian cancer	0.000174	0.000636	CcSEcCtD
Clofarabine—Myalgia—Paclitaxel—ovarian cancer	0.000174	0.000635	CcSEcCtD
Clofarabine—Arthralgia—Paclitaxel—ovarian cancer	0.000174	0.000635	CcSEcCtD
Clofarabine—Anxiety—Paclitaxel—ovarian cancer	0.000173	0.000632	CcSEcCtD
Clofarabine—Erythema—Docetaxel—ovarian cancer	0.000173	0.000632	CcSEcCtD
Clofarabine—Malnutrition—Docetaxel—ovarian cancer	0.000173	0.000632	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000173	0.00063	CcSEcCtD
Clofarabine—Nausea—Topotecan—ovarian cancer	0.000172	0.000628	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CHEK2—ovarian cancer	0.000171	0.00103	CbGpPWpGaD
Clofarabine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000171	0.000624	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—ovarian cancer	0.00017	0.00102	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.00017	0.00102	CbGpPWpGaD
Clofarabine—Diarrhoea—Vinorelbine—ovarian cancer	0.00017	0.000619	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000169	0.00102	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000169	0.00101	CbGpPWpGaD
Clofarabine—Nausea—Melphalan—ovarian cancer	0.000169	0.000615	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYTB—ovarian cancer	0.000169	0.00101	CbGpPWpGaD
Clofarabine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000168	0.000613	CcSEcCtD
Clofarabine—Influenza—Epirubicin—ovarian cancer	0.000168	0.000612	CcSEcCtD
Clofarabine—Back pain—Docetaxel—ovarian cancer	0.000167	0.000611	CcSEcCtD
Clofarabine—Dehydration—Doxorubicin—ovarian cancer	0.000167	0.000609	CcSEcCtD
Clofarabine—Oedema—Paclitaxel—ovarian cancer	0.000167	0.000608	CcSEcCtD
Clofarabine—Infection—Paclitaxel—ovarian cancer	0.000166	0.000604	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000165	0.000991	CbGpPWpGaD
Clofarabine—Dry skin—Doxorubicin—ovarian cancer	0.000164	0.0006	CcSEcCtD
Clofarabine—Pancreatitis—Epirubicin—ovarian cancer	0.000164	0.0006	CcSEcCtD
Clofarabine—Dizziness—Vinorelbine—ovarian cancer	0.000164	0.000598	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000164	0.000598	CcSEcCtD
Clofarabine—POLA1—S Phase—CDKN1B—ovarian cancer	0.000164	0.000981	CbGpPWpGaD
Clofarabine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000164	0.000597	CcSEcCtD
Clofarabine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000163	0.000596	CcSEcCtD
Clofarabine—Tachycardia—Paclitaxel—ovarian cancer	0.000163	0.000594	CcSEcCtD
Clofarabine—Skin disorder—Paclitaxel—ovarian cancer	0.000162	0.000591	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000162	0.00059	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000162	0.00059	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000161	0.000966	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000161	0.000588	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000161	0.000964	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BRCA1—ovarian cancer	0.000161	0.000962	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND2—ovarian cancer	0.000161	0.000962	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.00016	0.00096	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.00016	0.00096	CbGpPWpGaD
Clofarabine—Anaemia—Docetaxel—ovarian cancer	0.00016	0.000584	CcSEcCtD
Clofarabine—Pancytopenia—Epirubicin—ovarian cancer	0.000159	0.000581	CcSEcCtD
Clofarabine—Anorexia—Paclitaxel—ovarian cancer	0.000159	0.00058	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000158	0.000577	CcSEcCtD
Clofarabine—Vomiting—Vinorelbine—ovarian cancer	0.000158	0.000575	CcSEcCtD
Clofarabine—DCK—Metabolism—CYTB—ovarian cancer	0.000157	0.000944	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000157	0.000942	CbGpPWpGaD
Clofarabine—Neutropenia—Epirubicin—ovarian cancer	0.000157	0.000572	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000156	0.000938	CbGpPWpGaD
Clofarabine—Rash—Vinorelbine—ovarian cancer	0.000156	0.00057	CcSEcCtD
Clofarabine—POLA1—S Phase—CCND1—ovarian cancer	0.000156	0.000936	CbGpPWpGaD
Clofarabine—Dermatitis—Vinorelbine—ovarian cancer	0.000156	0.00057	CcSEcCtD
Clofarabine—Hypotension—Paclitaxel—ovarian cancer	0.000156	0.000568	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000156	0.000568	CcSEcCtD
Clofarabine—Headache—Vinorelbine—ovarian cancer	0.000155	0.000567	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—ovarian cancer	0.000155	0.000566	CcSEcCtD
Clofarabine—Leukopenia—Docetaxel—ovarian cancer	0.000155	0.000566	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PPP2R1A—ovarian cancer	0.000155	0.000928	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000154	0.000925	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000153	0.000917	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000153	0.000917	CbGpPWpGaD
Clofarabine—Pancreatitis—Doxorubicin—ovarian cancer	0.000152	0.000555	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000152	0.000911	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000152	0.000554	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—ovarian cancer	0.000152	0.000553	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—PPP2R1A—ovarian cancer	0.000151	0.000907	CbGpPWpGaD
Clofarabine—Cough—Docetaxel—ovarian cancer	0.000151	0.000551	CcSEcCtD
Clofarabine—Pneumonia—Epirubicin—ovarian cancer	0.00015	0.000549	CcSEcCtD
Clofarabine—Paraesthesia—Paclitaxel—ovarian cancer	0.00015	0.000546	CcSEcCtD
Clofarabine—Hypertension—Docetaxel—ovarian cancer	0.00015	0.000545	CcSEcCtD
Clofarabine—Infestation—Epirubicin—ovarian cancer	0.000149	0.000545	CcSEcCtD
Clofarabine—Infestation NOS—Epirubicin—ovarian cancer	0.000149	0.000545	CcSEcCtD
Clofarabine—Dyspnoea—Paclitaxel—ovarian cancer	0.000149	0.000542	CcSEcCtD
Clofarabine—Somnolence—Paclitaxel—ovarian cancer	0.000148	0.000541	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000148	0.000541	CcSEcCtD
Clofarabine—Myalgia—Docetaxel—ovarian cancer	0.000147	0.000538	CcSEcCtD
Clofarabine—Arthralgia—Docetaxel—ovarian cancer	0.000147	0.000538	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—ovarian cancer	0.000147	0.000537	CcSEcCtD
Clofarabine—RRM2—Metabolism—PPP1CC—ovarian cancer	0.000147	0.000883	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—BRIP1—ovarian cancer	0.000147	0.000883	CbGpPWpGaD
Clofarabine—Nausea—Vinorelbine—ovarian cancer	0.000147	0.000537	CcSEcCtD
Clofarabine—Renal failure—Epirubicin—ovarian cancer	0.000147	0.000536	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000147	0.000535	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000146	0.000534	CcSEcCtD
Clofarabine—Jaundice—Epirubicin—ovarian cancer	0.000146	0.000532	CcSEcCtD
Clofarabine—Stomatitis—Epirubicin—ovarian cancer	0.000146	0.000532	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—BRCA2—ovarian cancer	0.000145	0.00087	CbGpPWpGaD
Clofarabine—Neutropenia—Doxorubicin—ovarian cancer	0.000145	0.000529	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.000145	0.000869	CbGpPWpGaD
Clofarabine—Decreased appetite—Paclitaxel—ovarian cancer	0.000145	0.000529	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MLH1—ovarian cancer	0.000145	0.000868	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000145	0.000866	CbGpPWpGaD
Clofarabine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000144	0.000526	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000144	0.000525	CcSEcCtD
Clofarabine—Fatigue—Paclitaxel—ovarian cancer	0.000144	0.000525	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—SKP2—ovarian cancer	0.000143	0.000858	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	0.000143	0.000857	CbGpPWpGaD
Clofarabine—Pain—Paclitaxel—ovarian cancer	0.000143	0.00052	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—ovarian cancer	0.000143	0.00052	CcSEcCtD
Clofarabine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000141	0.000516	CcSEcCtD
Clofarabine—Oedema—Docetaxel—ovarian cancer	0.000141	0.000516	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—ovarian cancer	0.000141	0.000514	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCNE1—ovarian cancer	0.000141	0.000843	CbGpPWpGaD
Clofarabine—Infection—Docetaxel—ovarian cancer	0.00014	0.000512	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—ovarian cancer	0.00014	0.000512	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—ovarian cancer	0.00014	0.000512	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—ovarian cancer	0.000139	0.000508	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—BIRC5—ovarian cancer	0.000139	0.000832	CbGpPWpGaD
Clofarabine—Nervous system disorder—Docetaxel—ovarian cancer	0.000139	0.000506	CcSEcCtD
Clofarabine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000138	0.000505	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—ovarian cancer	0.000138	0.000505	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—ovarian cancer	0.000138	0.000505	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TYMS—ovarian cancer	0.000138	0.000828	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—ovarian cancer	0.000138	0.000827	CbGpPWpGaD
Clofarabine—Tachycardia—Docetaxel—ovarian cancer	0.000138	0.000503	CcSEcCtD
Clofarabine—DCK—Metabolism—BRIP1—ovarian cancer	0.000138	0.000825	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPP1CC—ovarian cancer	0.000138	0.000825	CbGpPWpGaD
Clofarabine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000137	0.000501	CcSEcCtD
Clofarabine—Skin disorder—Docetaxel—ovarian cancer	0.000137	0.000501	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000137	0.0005	CcSEcCtD
Clofarabine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000136	0.000497	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—ovarian cancer	0.000136	0.000496	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000136	0.000814	CbGpPWpGaD
Clofarabine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000136	0.000495	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—ovarian cancer	0.000135	0.000492	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—ovarian cancer	0.000135	0.000492	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—ovarian cancer	0.000135	0.000492	CcSEcCtD
Clofarabine—Anorexia—Docetaxel—ovarian cancer	0.000135	0.000492	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—ovarian cancer	0.000134	0.00049	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000133	0.000796	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000132	0.000483	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—ovarian cancer	0.000132	0.000482	CcSEcCtD
Clofarabine—Hypotension—Docetaxel—ovarian cancer	0.000132	0.000482	CcSEcCtD
Clofarabine—Haematuria—Doxorubicin—ovarian cancer	0.000132	0.000481	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000132	0.000481	CcSEcCtD
Clofarabine—Abdominal pain—Paclitaxel—ovarian cancer	0.000132	0.000481	CcSEcCtD
Clofarabine—Body temperature increased—Paclitaxel—ovarian cancer	0.000132	0.000481	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—ovarian cancer	0.000132	0.00048	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000131	0.000477	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—ovarian cancer	0.00013	0.000476	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—ovarian cancer	0.00013	0.000473	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000129	0.00047	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000128	0.00077	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—ovarian cancer	0.000127	0.000761	CbGpPWpGaD
Clofarabine—Paraesthesia—Docetaxel—ovarian cancer	0.000127	0.000463	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—ovarian cancer	0.000127	0.000463	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—ovarian cancer	0.000126	0.00046	CcSEcCtD
Clofarabine—Somnolence—Docetaxel—ovarian cancer	0.000126	0.000458	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—ovarian cancer	0.000125	0.000751	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000125	0.00075	CbGpPWpGaD
Clofarabine—Haemoglobin—Doxorubicin—ovarian cancer	0.000125	0.000455	CcSEcCtD
Clofarabine—Flushing—Epirubicin—ovarian cancer	0.000125	0.000454	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—ovarian cancer	0.000125	0.000454	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000124	0.000745	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BIRC5—ovarian cancer	0.000124	0.000744	CbGpPWpGaD
Clofarabine—Haemorrhage—Doxorubicin—ovarian cancer	0.000124	0.000453	CcSEcCtD
Clofarabine—Decreased appetite—Docetaxel—ovarian cancer	0.000123	0.000448	CcSEcCtD
Clofarabine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000123	0.000448	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000123	0.000736	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000123	0.000447	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	0.000123	0.000734	CbGpPWpGaD
Clofarabine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000122	0.000446	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000122	0.000445	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000122	0.000445	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—ovarian cancer	0.000122	0.000445	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—ovarian cancer	0.000122	0.000444	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—ovarian cancer	0.000122	0.000444	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—ovarian cancer	0.000121	0.000442	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000121	0.000441	CcSEcCtD
Clofarabine—Pain—Docetaxel—ovarian cancer	0.000121	0.000441	CcSEcCtD
Clofarabine—Chills—Epirubicin—ovarian cancer	0.00012	0.000439	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TERT—ovarian cancer	0.00012	0.000721	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—YAP1—ovarian cancer	0.00012	0.000719	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00012	0.000719	CbGpPWpGaD
Clofarabine—Asthenia—Paclitaxel—ovarian cancer	0.00012	0.000436	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—ovarian cancer	0.000119	0.000433	CcSEcCtD
Clofarabine—Pruritus—Paclitaxel—ovarian cancer	0.000118	0.00043	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—ovarian cancer	0.000118	0.000429	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000117	0.000428	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CHEK2—ovarian cancer	0.000117	0.000702	CbGpPWpGaD
Clofarabine—Erythema—Epirubicin—ovarian cancer	0.000117	0.000426	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—ovarian cancer	0.000117	0.000426	CcSEcCtD
Clofarabine—Feeling abnormal—Docetaxel—ovarian cancer	0.000116	0.000425	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—ovarian cancer	0.000116	0.000697	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000116	0.000694	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000116	0.000422	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—ovarian cancer	0.000115	0.00042	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000115	0.00042	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000115	0.00069	CbGpPWpGaD
Clofarabine—Diarrhoea—Paclitaxel—ovarian cancer	0.000114	0.000416	CcSEcCtD
Clofarabine—Back pain—Epirubicin—ovarian cancer	0.000113	0.000412	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000113	0.000676	CbGpPWpGaD
Clofarabine—Angiopathy—Doxorubicin—ovarian cancer	0.000113	0.000411	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—ovarian cancer	0.000112	0.000409	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000112	0.000408	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—ovarian cancer	0.000112	0.000408	CcSEcCtD
Clofarabine—Abdominal pain—Docetaxel—ovarian cancer	0.000112	0.000408	CcSEcCtD
Clofarabine—Chills—Doxorubicin—ovarian cancer	0.000111	0.000406	CcSEcCtD
Clofarabine—Dizziness—Paclitaxel—ovarian cancer	0.00011	0.000402	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00011	0.000658	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND2—ovarian cancer	0.00011	0.000658	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BRCA1—ovarian cancer	0.00011	0.000658	CbGpPWpGaD
Clofarabine—Alopecia—Doxorubicin—ovarian cancer	0.00011	0.0004	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000109	0.000652	CbGpPWpGaD
Clofarabine—Mental disorder—Doxorubicin—ovarian cancer	0.000109	0.000397	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000108	0.00065	CbGpPWpGaD
Clofarabine—Erythema—Doxorubicin—ovarian cancer	0.000108	0.000394	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—ovarian cancer	0.000108	0.000394	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—ovarian cancer	0.000108	0.000394	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000108	0.000645	CbGpPWpGaD
Clofarabine—Agitation—Epirubicin—ovarian cancer	0.000107	0.000392	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000106	0.000635	CbGpPWpGaD
Clofarabine—Vomiting—Paclitaxel—ovarian cancer	0.000106	0.000387	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000106	0.000633	CbGpPWpGaD
Clofarabine—Rash—Paclitaxel—ovarian cancer	0.000105	0.000384	CcSEcCtD
Clofarabine—Dermatitis—Paclitaxel—ovarian cancer	0.000105	0.000383	CcSEcCtD
Clofarabine—Leukopenia—Epirubicin—ovarian cancer	0.000105	0.000381	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—ovarian cancer	0.000105	0.000381	CcSEcCtD
Clofarabine—Headache—Paclitaxel—ovarian cancer	0.000104	0.000381	CcSEcCtD
Clofarabine—Hypersensitivity—Docetaxel—ovarian cancer	0.000104	0.00038	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—PPP2R1A—ovarian cancer	0.000104	0.000621	CbGpPWpGaD
Clofarabine—Cough—Epirubicin—ovarian cancer	0.000102	0.000372	CcSEcCtD
Clofarabine—Asthenia—Docetaxel—ovarian cancer	0.000101	0.00037	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—ovarian cancer	0.000101	0.000368	CcSEcCtD
Clofarabine—Pruritus—Docetaxel—ovarian cancer	0.0001	0.000365	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—ovarian cancer	9.99e-05	0.000364	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—ovarian cancer	9.94e-05	0.000363	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—ovarian cancer	9.94e-05	0.000363	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—ovarian cancer	9.93e-05	0.000362	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BRCA2—ovarian cancer	9.93e-05	0.000595	CbGpPWpGaD
Clofarabine—Anxiety—Epirubicin—ovarian cancer	9.91e-05	0.000362	CcSEcCtD
Clofarabine—Nausea—Paclitaxel—ovarian cancer	9.9e-05	0.000361	CcSEcCtD
Clofarabine—RRM2—Metabolism—YAP1—ovarian cancer	9.88e-05	0.000592	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	9.88e-05	0.00036	CcSEcCtD
Clofarabine—RRM1—Metabolism—FASN—ovarian cancer	9.78e-05	0.000586	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NME2—ovarian cancer	9.78e-05	0.000586	CbGpPWpGaD
Clofarabine—Leukopenia—Doxorubicin—ovarian cancer	9.67e-05	0.000353	CcSEcCtD
Clofarabine—Diarrhoea—Docetaxel—ovarian cancer	9.67e-05	0.000353	CcSEcCtD
Clofarabine—RRM1—Metabolism—SLC5A5—ovarian cancer	9.62e-05	0.000577	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCNE1—ovarian cancer	9.62e-05	0.000576	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	9.58e-05	0.000574	CbGpPWpGaD
Clofarabine—Oedema—Epirubicin—ovarian cancer	9.53e-05	0.000348	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—ovarian cancer	9.5e-05	0.000569	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	9.48e-05	0.000568	CbGpPWpGaD
Clofarabine—Infection—Epirubicin—ovarian cancer	9.47e-05	0.000346	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TYMS—ovarian cancer	9.44e-05	0.000566	CbGpPWpGaD
Clofarabine—Cough—Doxorubicin—ovarian cancer	9.43e-05	0.000344	CcSEcCtD
Clofarabine—Nervous system disorder—Epirubicin—ovarian cancer	9.35e-05	0.000341	CcSEcCtD
Clofarabine—Dizziness—Docetaxel—ovarian cancer	9.35e-05	0.000341	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—ovarian cancer	9.33e-05	0.000341	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—ovarian cancer	9.33e-05	0.00034	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—ovarian cancer	9.3e-05	0.000339	CcSEcCtD
Clofarabine—RRM1—Metabolism—SLC2A1—ovarian cancer	9.29e-05	0.000557	CbGpPWpGaD
Clofarabine—Skin disorder—Epirubicin—ovarian cancer	9.26e-05	0.000338	CcSEcCtD
Clofarabine—DCK—Metabolism—YAP1—ovarian cancer	9.23e-05	0.000553	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—ovarian cancer	9.21e-05	0.000336	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—ovarian cancer	9.2e-05	0.000336	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—ovarian cancer	9.2e-05	0.000336	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—ovarian cancer	9.17e-05	0.000335	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	9.14e-05	0.000333	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—ovarian cancer	9.09e-05	0.000332	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	9.06e-05	0.000543	CbGpPWpGaD
Clofarabine—Vomiting—Docetaxel—ovarian cancer	8.99e-05	0.000328	CcSEcCtD
Clofarabine—Rash—Docetaxel—ovarian cancer	8.91e-05	0.000325	CcSEcCtD
Clofarabine—Hypotension—Epirubicin—ovarian cancer	8.91e-05	0.000325	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP1B1—ovarian cancer	8.91e-05	0.000534	CbGpPWpGaD
Clofarabine—Dermatitis—Docetaxel—ovarian cancer	8.9e-05	0.000325	CcSEcCtD
Clofarabine—Headache—Docetaxel—ovarian cancer	8.85e-05	0.000323	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—ovarian cancer	8.82e-05	0.000322	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	8.81e-05	0.000528	CbGpPWpGaD
Clofarabine—Infection—Doxorubicin—ovarian cancer	8.76e-05	0.00032	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.68e-05	0.000317	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—ovarian cancer	8.65e-05	0.000316	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—ovarian cancer	8.64e-05	0.000315	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	8.62e-05	0.000517	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	8.62e-05	0.000517	CbGpPWpGaD
Clofarabine—Tachycardia—Doxorubicin—ovarian cancer	8.61e-05	0.000314	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—ovarian cancer	8.57e-05	0.000313	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—ovarian cancer	8.56e-05	0.000312	CcSEcCtD
Clofarabine—Hyperhidrosis—Doxorubicin—ovarian cancer	8.53e-05	0.000311	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—ovarian cancer	8.5e-05	0.00031	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BIRC5—ovarian cancer	8.49e-05	0.000509	CbGpPWpGaD
Clofarabine—Somnolence—Epirubicin—ovarian cancer	8.47e-05	0.000309	CcSEcCtD
Clofarabine—Anorexia—Doxorubicin—ovarian cancer	8.41e-05	0.000307	CcSEcCtD
Clofarabine—Nausea—Docetaxel—ovarian cancer	8.39e-05	0.000306	CcSEcCtD
Clofarabine—Decreased appetite—Epirubicin—ovarian cancer	8.29e-05	0.000302	CcSEcCtD
Clofarabine—Hypotension—Doxorubicin—ovarian cancer	8.24e-05	0.000301	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.23e-05	0.0003	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TERT—ovarian cancer	8.23e-05	0.000493	CbGpPWpGaD
Clofarabine—Fatigue—Epirubicin—ovarian cancer	8.22e-05	0.0003	CcSEcCtD
Clofarabine—Pain—Epirubicin—ovarian cancer	8.15e-05	0.000297	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	8.15e-05	0.000488	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	8.14e-05	0.000488	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—FASN—ovarian cancer	8.05e-05	0.000483	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.04e-05	0.000293	CcSEcCtD
Clofarabine—RRM2—Metabolism—SLC5A5—ovarian cancer	7.92e-05	0.000475	CbGpPWpGaD
Clofarabine—Paraesthesia—Doxorubicin—ovarian cancer	7.92e-05	0.000289	CcSEcCtD
Clofarabine—RRM1—Metabolism—PPP2R1A—ovarian cancer	7.9e-05	0.000473	CbGpPWpGaD
Clofarabine—Dyspnoea—Doxorubicin—ovarian cancer	7.86e-05	0.000287	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—ovarian cancer	7.86e-05	0.000287	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—ovarian cancer	7.84e-05	0.000286	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	7.82e-05	0.000469	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Epirubicin—ovarian cancer	7.79e-05	0.000284	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—ovarian cancer	7.78e-05	0.000466	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—ovarian cancer	7.67e-05	0.00028	CcSEcCtD
Clofarabine—RRM2—Metabolism—SLC2A1—ovarian cancer	7.65e-05	0.000459	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.61e-05	0.000278	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—ovarian cancer	7.6e-05	0.000277	CcSEcCtD
Clofarabine—Pain—Doxorubicin—ovarian cancer	7.54e-05	0.000275	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—ovarian cancer	7.54e-05	0.000275	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—ovarian cancer	7.54e-05	0.000275	CcSEcCtD
Clofarabine—DCK—Metabolism—FASN—ovarian cancer	7.53e-05	0.000451	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.48e-05	0.000448	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC5A5—ovarian cancer	7.4e-05	0.000444	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCB1—ovarian cancer	7.33e-05	0.00044	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1B1—ovarian cancer	7.33e-05	0.00044	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—ovarian cancer	7.29e-05	0.000437	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—ovarian cancer	7.27e-05	0.000265	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.24e-05	0.000434	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.21e-05	0.000263	CcSEcCtD
Clofarabine—RRM1—Metabolism—TYMS—ovarian cancer	7.2e-05	0.000432	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC2A1—ovarian cancer	7.15e-05	0.000428	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—ovarian cancer	7.02e-05	0.000256	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—ovarian cancer	6.97e-05	0.000254	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—ovarian cancer	6.97e-05	0.000254	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—ovarian cancer	6.95e-05	0.000417	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1B1—ovarian cancer	6.85e-05	0.000411	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—ovarian cancer	6.84e-05	0.00025	CcSEcCtD
Clofarabine—Pruritus—Epirubicin—ovarian cancer	6.74e-05	0.000246	CcSEcCtD
Clofarabine—Diarrhoea—Epirubicin—ovarian cancer	6.52e-05	0.000238	CcSEcCtD
Clofarabine—RRM2—Metabolism—PPP2R1A—ovarian cancer	6.51e-05	0.00039	CbGpPWpGaD
Clofarabine—Hypersensitivity—Doxorubicin—ovarian cancer	6.5e-05	0.000237	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—ovarian cancer	6.41e-05	0.000384	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—ovarian cancer	6.33e-05	0.000231	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.32e-05	0.000379	CbGpPWpGaD
Clofarabine—Dizziness—Epirubicin—ovarian cancer	6.3e-05	0.00023	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CYTB—ovarian cancer	6.3e-05	0.000378	CbGpPWpGaD
Clofarabine—Pruritus—Doxorubicin—ovarian cancer	6.24e-05	0.000228	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—ovarian cancer	6.24e-05	0.000374	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.11e-05	0.000366	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.11e-05	0.000366	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK1—ovarian cancer	6.1e-05	0.000366	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPP2R1A—ovarian cancer	6.08e-05	0.000364	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—ovarian cancer	6.06e-05	0.000221	CcSEcCtD
Clofarabine—RRM2—Metabolism—ABCB1—ovarian cancer	6.04e-05	0.000362	CbGpPWpGaD
Clofarabine—Diarrhoea—Doxorubicin—ovarian cancer	6.03e-05	0.00022	CcSEcCtD
Clofarabine—Rash—Epirubicin—ovarian cancer	6.01e-05	0.000219	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—ovarian cancer	6e-05	0.000219	CcSEcCtD
Clofarabine—Headache—Epirubicin—ovarian cancer	5.97e-05	0.000218	CcSEcCtD
Clofarabine—RRM2—Metabolism—TYMS—ovarian cancer	5.93e-05	0.000356	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—ovarian cancer	5.86e-05	0.000351	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—ovarian cancer	5.83e-05	0.000213	CcSEcCtD
Clofarabine—RRM1—Metabolism—CAV1—ovarian cancer	5.8e-05	0.000348	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK3—ovarian cancer	5.73e-05	0.000344	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—ovarian cancer	5.66e-05	0.000207	CcSEcCtD
Clofarabine—DCK—Metabolism—ABCB1—ovarian cancer	5.64e-05	0.000338	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—ovarian cancer	5.61e-05	0.000205	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—ovarian cancer	5.58e-05	0.000334	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—ovarian cancer	5.58e-05	0.000334	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.57e-05	0.000334	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—ovarian cancer	5.56e-05	0.000203	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—ovarian cancer	5.56e-05	0.000203	CcSEcCtD
Clofarabine—DCK—Metabolism—TYMS—ovarian cancer	5.54e-05	0.000332	CbGpPWpGaD
Clofarabine—Headache—Doxorubicin—ovarian cancer	5.53e-05	0.000202	CcSEcCtD
Clofarabine—ABCG2—Metabolism—BRIP1—ovarian cancer	5.51e-05	0.00033	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPP1CC—ovarian cancer	5.51e-05	0.00033	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK1—ovarian cancer	5.46e-05	0.000327	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.32e-05	0.000319	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—ovarian cancer	5.29e-05	0.000317	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—ovarian cancer	5.24e-05	0.000191	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN1B—ovarian cancer	4.98e-05	0.000299	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.82e-05	0.000289	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAV1—ovarian cancer	4.78e-05	0.000286	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—ovarian cancer	4.76e-05	0.000285	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—ovarian cancer	4.65e-05	0.000279	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—ovarian cancer	4.58e-05	0.000274	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAV1—ovarian cancer	4.47e-05	0.000268	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.39e-05	0.000263	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—ovarian cancer	4.35e-05	0.000261	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—ovarian cancer	4.27e-05	0.000256	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.17e-05	0.00025	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—ovarian cancer	4.07e-05	0.000244	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—ovarian cancer	4.05e-05	0.000243	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK3—ovarian cancer	3.92e-05	0.000235	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—ovarian cancer	3.83e-05	0.000229	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—ovarian cancer	3.81e-05	0.000229	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK1—ovarian cancer	3.73e-05	0.000224	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—YAP1—ovarian cancer	3.69e-05	0.000221	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—ovarian cancer	3.58e-05	0.000214	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—ovarian cancer	3.5e-05	0.00021	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—ovarian cancer	3.34e-05	0.0002	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—ovarian cancer	3.13e-05	0.000188	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—ovarian cancer	3.12e-05	0.000187	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FASN—ovarian cancer	3.01e-05	0.00018	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A5—ovarian cancer	2.96e-05	0.000178	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—ovarian cancer	2.88e-05	0.000173	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A1—ovarian cancer	2.86e-05	0.000171	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1B1—ovarian cancer	2.74e-05	0.000164	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—ovarian cancer	2.69e-05	0.000161	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—ovarian cancer	2.47e-05	0.000148	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPP2R1A—ovarian cancer	2.43e-05	0.000146	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—ovarian cancer	2.26e-05	0.000135	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—ovarian cancer	2.22e-05	0.000133	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—ovarian cancer	2.03e-05	0.000122	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—ovarian cancer	2.02e-05	0.000121	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—ovarian cancer	1.9e-05	0.000114	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAV1—ovarian cancer	1.79e-05	0.000107	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—ovarian cancer	1.66e-05	9.96e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.63e-05	9.76e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—ovarian cancer	1.55e-05	9.3e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—ovarian cancer	1.43e-05	8.58e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—ovarian cancer	1.25e-05	7.48e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—ovarian cancer	1.08e-05	6.46e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—ovarian cancer	7.61e-06	4.56e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—ovarian cancer	6.21e-06	3.72e-05	CbGpPWpGaD
